Incannex Healthcare Files 8-K
Ticker: IXHL · Form: 8-K · Filed: Feb 4, 2025 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Feb 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-filing
TL;DR
Incannex Healthcare filed an 8-K on Feb 4, 2025. Standard reporting.
AI Summary
Incannex Healthcare Inc. filed an 8-K on February 4, 2025, reporting other events and financial statements. The company, previously known as Incannex Healthcare Ltd until July 20, 2021, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides an update on Incannex Healthcare's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, indicating standard corporate reporting rather than a significant event.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- Incannex Healthcare Ltd (company) — Former company name
- February 4, 2025 (date) — Date of earliest event reported
- 20210720 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of February 4, 2025.
What was Incannex Healthcare Inc.'s former name?
Incannex Healthcare Inc.'s former name was Incannex Healthcare Ltd, with a date of name change on July 20, 2021.
In which state is Incannex Healthcare Inc. incorporated?
Incannex Healthcare Inc. is incorporated in Delaware.
What is the Standard Industrial Classification (SIC) code for Incannex Healthcare Inc.?
The SIC code for Incannex Healthcare Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the principal executive office address listed in the filing?
The address of the Principal Executive Offices is Suite 105, 8 Century Circuit, Norwest, NSW 2153, Australia.
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-02-04 09:20:07
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0229576-8k_incannex.htm (8-K) — 36KB
- ea022957601ex99-1_incannex.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-25-009715.txt ( ) — 229KB
- ixhl-20250204.xsd (EX-101.SCH) — 3KB
- ixhl-20250204_lab.xml (EX-101.LAB) — 33KB
- ixhl-20250204_pre.xml (EX-101.PRE) — 22KB
- ea0229576-8k_incannex_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: February 4, 2025 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2